Image

Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities

Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to find out which approach works better in getting more of the friends and connections of Latino adults get vaccinated against COVID-19.

The main questions this study aims to answer are:

  1. Can teaching people to use motivational interviewing help more friends and connections of Latino adults get the COVID-19 vaccine compared to just giving information about the vaccine?
  2. What are the things that make it easier or harder for Latinos and networks to get the COVID-19 vaccine?
  3. How does this intervention work in practice so that it can be made available to more people in the future

The researchers will compare the vaccine rates of the friends and connections of Latinos who have been trained in motivational interviewing with those who have only been given information about the COVID-19 vaccine. This will help figure out which method works best to encourage more people to get vaccinated.

Description

This study will test the efficacy of an intervention REDES ("Networks") - a social network intervention - to address COVID-19 vaccine hesitancy and uptake among a cohort of Latinos and networks. 300 index participants who have taken the COVID-19 vaccine will be recruited. Half of the index participants (n=150) will be randomized to the experimental group and will receive training on motivational interviewing to promote vaccine acceptance and uptake with networks. Index participants in the control group (n=150) will receive updated information about the COVID-19 vaccine. In addition, unvaccinated primary and secondary network members of indexes will be recruited for study participation and COVID-19 vaccination. All participants will be followed prospectively at 6, 12, and 18 months after baseline intake. The specific aims are: 1) Evaluate the efficacy of the REDES intervention to promote COVID-19 vaccine uptake among Latinos; 2) Examine ongoing barriers and facilitators of vaccine uptake among Latinos and networks to tailor the intervention and address new challenges, and 3) Evaluate the implementation determinants and outcomes of REDES to inform future broad-scale implementation.

Eligibility

Inclusion Criteria:

        Eligibility criteria for index participants (eligibility for index participants is intended
        to select participants who are less vaccine hesitant):
          -  Age 18 years or older, and
          -  Self-identifies as Hispanic/Latino, and
          -  Living in Maryland, and
          -  Has received at least one COVID-19 vaccine/booster in the last 12 months.
        Eligibility criteria for primary and secondary network members (peers):
        Eligibility for peers is intended to select for participants who are more vaccine hesitant
        (e.g. unvaccinated, or have not received at least one COVID-19 vaccine/booster in the last
        12 months)
          -  18 years old or older, and
          -  Self-identifies as Hispanic/Latino, and
          -  Living in Maryland, and
          -  Provide a study coupon to verify that they were referred by an index or a primary
             network member, and
          -  Has not received at least one COVID-19 vaccine/booster in the last 12 months.
        Exclusion Criteria:
          -  Previously participated in the study
          -  Lacks capacity to consent

Study details
    COVID-19
    Vaccine

NCT06128928

Johns Hopkins University

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.